|
|
|
|
|
| |
|
| Admission
to Ph.D. Programme |
 |
|
|
|
|
| |
|
|
| |
|
|
| |
|
CDRI
is a pioneer research organization in the
field of biomedical research in India. It
has the infrastructure and expertise to
develop a drug right from the concept stage
to the market. The institute’s latest
techniques and services are employed for
developing drugs, diagnostics and vaccines
to combat diseases prevalent among mankind
in general and Indian population in particular.
Since its establishment, on 17th Feb. 1951,
the institute has provided leadership on
all fronts of drug R&D, namely, development
of new molecules, novel products, cost-effective
indigenous process know how for institute’s
candidate drugs and generic drugs/drug intermediates,
quality research manpower and trainings
in use of sophisticated tools and techniques
in drug research. Several of the institute
products and process know how have been
successfully commercialized leading to treatment
of diseases, products availability for indigenous
and international markets and generation
of foreign exchange. Besides, the Institute
has played a critical role in putting the
country on the international scene in drug
R&D.
CDRI trains a large number of students
and has a robust Ph.D. program in different
areas of Life sciences/Biotechnology/Chemical/Pharmaceutical
sciences, directed towards new drug development.
CDRI provides a vibrant academic atmosphere
enabling inter-disciplinary and cross-disciplinary
areas of research to flourish. The R &
D divisions of CDRI where students can
pursue their Ph. D. studies are as follows
:
|
| |
|
• Biochemistry
• Botany
• Clinical & Experimental Medicine
• Drug Target Discovery & Development
• Endocrinology
• Fermentation Technology
• Medicinal & Process Chemistry
Division
• Microbiology
• Molecular & Structural Biology
• Parasitology
• Pharmaceutics
• Pharmacokinetics & Metabolism
• Pharmacology
• Toxicology
|
| |
|
| Thrust
areas of research and their objectives
are : |
| |
Malaria
and other Parasitic Diseases
• Development of new drugs/drug
combinations as therapeutic interventions
for malaria, leishmaniasis and filariasis
• Establish novel target based
drug assay protocols for identification
of new leads;
• Knowledge
generation on parasite biology and host
parasite interactions.
|
|
Reproductive
Health Research, Diabetes & Energy
Metabolism
• Development
of novel agents for fertility regulation,
management of post-menopausal osteoporosis,
type II diabetes mellitus, hyperlipidemic
condition and other endocrine disorders
through modern drug design, scientific
validation of traditional remedies;
• Understanding pharmacological
basis of actions of promising agents
& existing therapeutics and undertake
basic research to generate new knowledge
on reproductive endocrinology relevant
to fertility regulation, osteoporosis
and diabetes.
|
|
Tuberculosis
and Microbial Infections
• Simplification and shortening
of treatment for drug-sensitive tuberculosis
and search of new treatments for MDR-TB;
• Development of new drugs for
bacterial, fungal and viral (HIV and
JEV) infections and tuberculosis.
|
|
CVS, CNS
and Related Disorders
•
Development of new target based drugs
to alleviate CVS, CNS and related disorders
(hypertension, dyslipidemia, atherosclerosis,
thrombosis, myocardial infarction, anxiety,
psychosis, dementia, stroke, stress,
gastric ulcers and inflammation);
• Carry out excellent basic research
to delineate the molecular mechanisms
of these pathologies so as to identify
suitable targets for drug discovery,
as well as to analyze the possible mechanism(s)
of action of the candidate drugs.
|
|
Cancer and
Related Areas
• Creation
of appropriate platform for interdisciplinary
collaborative research;
•
Creation of knowledge base in cancer
biology;
• Lead identification/optimization
to obtain drug-like molecules.
|
|
Safety &
Clinical Development
•
Pre-clinical, clinical development and
commercialization of new generation
affordable drugs for diseases of national
importance and international relevance;
• Center of excellence in
the field of Clinical trials, Regulatory
toxicology, Safety pharmacology, Pharmaceutics
and Pharmacokinetics & metabolism
and catering to the needs of pharmaceutical
industries.
|
|
Excellent
synthetic organic chemistry/medicinal
chemistry group contributes to all the
above research areas in CDRI
Over the last six
decades, CDRI has built a unique model
for drug research in India –
having everything under one roof,
from synthesis, screening, development
studies, process up-scaling to clinical
studies. Keeping in view of the paradigm
shift in drug R&D approaches in
the last decade, the institute has
upgraded its capabilities and strengths
to match global standards. The major
R&D facilities available at CDRI
include overall S&T base for drug
discovery & development; Molecular
& structural biology equipped
with modern facilities for characterization
of drug targets and elucidation of
mechanism of action; High-throughput
screening; Drug quality control, standardization
and formulation development; Chemical
and fermentation technology development;
Sophisticated Analytical Instrument
Facility equipped with state of the
art analytical equipments; National
centre for pharmacokinetic and metabolic
studies; National facility for regulatory
pharmacology & toxicology; and
Knowledge resource centre for the
scientists and entrepreneurs involved
in biomedical research and pharmaceutical
industry.
CDRI research programs envisage to
rapidly adopt new approaches and technologies
in order to build up its capabilities
in drug discovery, research and development.
The overall scenario is very promising
as the institute have all the expertise,
state of the art facilities, ready
for shift newly constructed state-of-the-art
institute, more than 150 scientists
from a wide range of disciplines,
360 technical staff, more than 450
research scholars, the institute is
poised to deliver new drugs and technologies
in the pursuit of affordable drugs
and healthcare for all. Students will
have ample opportunities to interact
with reputed scientists of the Institute,
other CSIR Laboratories and fraternity
from Lucknow, national and international
laboratories. Students are permitted
to attend the conferences at national
and international platforms.
|
|
| |
|
The PhD program at CDRI consists of flexible
course work, followed by advanced research
leading to a PhD thesis on a specific
topic. The PhD program is normally completed
in 4-5 years.
Admission
to the PhD program
|
| |
|
|
| |
|
Eligibility
|
| |
|
| |
M.Sc. or equivalent degree in Life sciences/Biotechnology/Chemical Sciences and qualified in CSIR-UGC-NET, ICMR, DBT examinations for Junior Research Fellowship |
|
GPAT qualified second year, 3rd Semester students pursuing M.S. (Pharm) or M. Pharm. in Pharmaceutics/ Pharmaceutical Technology/Pharmacology/Pharmaco-Toxicology disciplines only may apply for GATE-JRF positions tenable at CDRI from July onwards after the completion of post graduation. |
|
| |
|
|
| |
|
How
to apply ? |
| |
|
Advertisement of Admission process and schedule of application subission etc. are advertised on our website twice a year (May and Sept).
(Click for
current Advertisement) |
| |
|
After the advertisement is uploaded, the desirous candidates need to fill up the on-line application form that is available at the institute’s website. |
| |
|
| |
After submitting the online application form, applicants need to get a print out of the system generated page containing the ID ticket.
|
|
Applicants are required to send the ID ticket along with their photograph, photocopies of certificates of date of birth, educational qualifications and proof for qualifying JRF/GPAT by post to Scientist-in-Charge, Academic Affairs Division, Central Drug Research Institute (CSIR), Chattar Manzil, Lucknow-226 001 |
|
The last date of receipt of documents is as per the schedule advertised. |
|
Applications without
hard copy submission of documents are
not considered. |
|
| |
|
|
| |
|
Selection
Procedure |
| |
|
| |
All
the applications are screened
by a committee. |
|
Candidates who are found suitable are called for written examination/interview/counselling at CDRI, Lucknow to be held on scheduled dates which are duly intimated to the selected applicants. |
|
The committee
sets up criteria for short listing
the candidates. |
|
No TA is paid
by CDRI |
|
Candidates
have to make their own arrangements
for 2-3 days stay at Lucknow. |
|
The number of students
to be selected will depend on the vacancies
available with scientists at CDRI. |
|
| |
|
|
| |
|
Seat
Availability |
| |
|
| |
Number
of seats available with each Scientist. (hyperlink to be available later) |
|
| |
|
|
| |
|
Emoluments |
| |
|
| |
Emoluments
and other benefits are advertised in
the advertisement put up by CSIR for
the CSIR NET Examination |
|
| |
|
|
| |
|
Accommodation |
| |
|
| |
A limited
Number of accommodation ( Both for boys
and girls) is available in the guest
house of C D R I situated at the CSIR
Apartments, Scetor K, Aliganj, Lucknow |
| |
The
Moti Mahal Trust situated at a walking
distance from the C D R I Campus also
provides hostel facilities to C D R
I Research students. |
|
| |
|
|
| |
|
General
Conditions |
| |
|
The
above fellowships are purely temporary and
selected candidates will have no claim explicitly
or implicitly for any post/position in any
of the CSIR Laboratories/Institutes including
CDRI. In general, CSIR rules/regulations
for selected candidates will be followed
to the extent they are applicable. |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
| |
|
website
copyright © Central Drug Research Institute.
All rights reserved.
No part of this should be Downloaded or used
in any way other than the non-commercial purposes
without prior permission of the Director,
CDRI. |
|
|
|
 |
| Powered
by MARG Software Solutions |
Contact
us |
You
are Visitor No. |
| Best viewed
at 800 X 600 Resolutions | Internet
Explorer 5.0 - Later Version |
<%
if session("iNumber")="" then
'conn.open mydsn
Dim rsHits
Set rsHits=Server.CreateObject("ADODB.Recordset")
rsHits.CursorLocation=adUseClient
rsHits.Open "Select visits from Hits", conn, adOpenKeyset, adLockOptimistic
session("iNumber")=rsHits("visits") + 1
rsHits("visits")=rsHits("visits") + 1
rsHits.Update
rsHits.Close
set rsHits=Nothing
end if
If Len(session("iNumber")) > 0 then
'Display iNumber
Response.Write "" & ConstructDigits(session("iNumber")) & ""
End If
''''
Function ConstructDigits(iValue)
'This function accepts a single parameter, iValue, and
'returns HTML containing a series of images representing
'a graphical image of the value in iValue
'Start by ensuring iValue is a number
If Not IsNumeric(iValue) then
ConstructDigits = iValue & " IS NOT A NUMBER!"
Exit Function
End If
'Can't show decimals!
If InStr(1, iValue, ".") then
ConstructDigits = "CANNOT CONTAIN DECIMALS!"
Exit Function
End If
'Can't show negative numbers!
If iValue < 0 then
ConstructDigits = "CANNOT DISPLAY NEGATIVE NUMBERS!"
Exit Function
End If
Dim iLoop, strResults
For iLoop = (Len(iValue) - 1) to 0 STEP -1
strResults = strResults & "![]() "
Next
ConstructDigits = strResults
End Function
''''
%>
|
|
|
|
|
|
|
